DMH1, a small molecule inhibitor of BMP type I receptors, suppresses growth and invasion of lung cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Hao, Jijun ^a   Lee, Rachel ^a   Chang, Andy ^a   Fan, Jeffery ^a   Labib, Chantelle ^a   Parsa, Cyrus ^a   Orlando, Robert ^a   Andresen, Bradley ^a   Huang, Ying ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; DMH1; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; ID1 GENE; ID2 GENE; ID3 GENE; LUNG ALVEOLUS CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84897141192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090748     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Kosaka T, Yamaki E, Mogi A, Kuwano H (2011) Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer. J Biomed Biotechnol 2011: 165214.
3. Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647.
4. Miyazono K, Maeda S, Imamura T (2005) BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine & Growth Factor Reviews 16: 251-263. (Pubitemid 40910315)
5. Levy L, Hill CS (2006) Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17: 41-58. (Pubitemid 43117515)
6. Langenfeld EM, Bojnowski J, Perone J, Langenfeld J (2005) Expression of bone morphogenetic proteins in human lung carcinomas. Annals of Thoracic Surgery 80: 1028-1032. (Pubitemid 41196808)
7. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, et al. (2003) The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24: 1445-1454. (Pubitemid 37160834)
8. Langenfeld EM, Kong Y, Langenfeld J (2006) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25: 685-692. (Pubitemid 43214695)
9. Feeley BT, Liu NQ, Conduah AH, Krenek L, Roth K, et al. (2006) Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank: Fc administration. Journal of Bone and Mineral Research 21: 1571-1580. (Pubitemid 44484602)
10. Lee KB, Murray SS, Duarte MEL, Spitz JF, Johnson JS, et al. (2011) Effects of the Bone Morphogenetic Protein Binding Protein spp24 (Secreted Phosphoprotein 24 kD) on the Growth of Human Lung Cancer Cells. Journal of Orthopaedic Research 29: 1712-1718.
11. Hao J, Ho JN, Lewis JA, Karim KA, Daniels RN, et al. (2010) In Vivo Structure-Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors. Acs Chemical Biology 5: 245-253.
12. Langenfeld E, Hong CC, Lanke G, Langenfeld J (2013) Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One 8: e61256.
13. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7: 1191-1204. (Pubitemid 36024597)
14. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, et al. (2007) ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A 104: 19506-19511.
15. Cory G (2011) Scratch-wound assay. Methods Mol Biol 769: 25-30.
16. Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, et al. (2008) Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27: 6322-6333.
17. Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG (2007) Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histology and Histopathology 22: 1129-1147. (Pubitemid 47470307)
18. Alarmo EL, Kallioniemi A (2010) Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer 17: R123-139.
19. Thawani JP, Wang AC, Than KD, Lin CY, La Marca F, et al. (2010) Bone Morphogenetic Proteins and Cancer: Review of the Literature. Neurosurgery 66: 233-246.
20. Langenfeld EM, Langenfeld J (2004) Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2: 141-149. (Pubitemid 39030304)
21. Alamgeer M, Peacock CD, Matsui W, Ganju V, Watkins DN (2013) Cancer stem cells in lung cancer: Evidence and controversies. Respirology 18: 757-764.
22. Langenfeld E, Deen M, Zachariah E, Langenfeld J (2013) Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer 12: 129.
23. Maegdefrau U, Bosserhoff AK (2012) BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. Exp Mol Pathol 92: 74-81.
24. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY (2004) Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 10: 2044-2051. (Pubitemid 38375565)